Sequelae of hyperalimentation

E4_HYPERALISEQ

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E68 Cause of death: ICD-10 — E68 2 out of 7 registries used, show all original rules.	74
4. Check minimum number of events None	74
5. Include endpoints None	74
6. Filter based on genotype QC (FinnGen only)	63

Control definitions (FinnGen only)

Control exclude: E4_OBESITY_HYPER

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E65-E68
Name in latin: Sequelae hyperalimentationis

NAME	E4_HYPERALISEQ
CONTROL_EXCLUDE	E4_OBESITY_HYPER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E68
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E68
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sequelae of hyperalimentation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	324	197	127
Only index persons	306	189	117
Unadjusted period prevalence (%)
Whole population	0.00	0.01	0.00
Only index persons	0.01	0.01	0.00
Median age at first event (years)
Whole population	-	49.24	58.24
Only index persons	52.05	48.89	57.17

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	63	43	20
Unadjusted period prevalence (%)	0.01	0.02	0.01
Median age at first event (years)	52.59	48.89	60.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
65: Matched controls
650

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E68

ICD-10 Finland

Sequelae of hyperalimentation

+∞

93.3

E66.8

ICD-10 Finland

Other obesity

254.7

30.6

E66.01

ICD-10 Finland

Obesity due to excess calories

32.1

24.5

E66.00

ICD-10 Finland

Metabolic syndrome

50.4

18.0

E66.9

ICD-10 Finland

Obesity, unspecified

104.0

15.3

QBJ30

NOMESCO Finland

Correction of abdominal apron

+∞

14.0

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

+∞

11.8

SPAT1262

SPAT

Handing over of treatment supplies

7.1

11.2

T82

ICPC

Obesity

23.8

10.9

M04AA01

ATC

allopurinol; systemic

6.3

9.3

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

+∞

8.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

20.6

8.4

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.5

7.7

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

7.2

7.7

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

18.5

7.5

103

Kela drug reimbursment

Diabetes, insulin-treated

4.4

7.5

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.3

6.9

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

+∞

6.3

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

5.0

6.3

E66

ICD-10 Finland

Obesity

11.7

6.3

C03CA01

ATC

furosemide; systemic

3.7

6.2

115

N02AX02

ATC

tramadol; systemic, rectal

3.7

6.2

196

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

3.8

6.2

109

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

12.8

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

4.62

7.91

2.1

1.6

1071.33

1201.39

nmol/l

0.31

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

230

4.42

7.31

3.0

1.9

102.29

99.14

pmol/l

0.14

114

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

239

3.87

6.17

3.8

2.5

67.16

77.29

nmol/l

1.83

223

(3020682) Albumin/Creatinine [Ratio] in Urine

161

3.33

5.39

6.2

3.5

7.25

6.46

mg/mmol

0.07

104

(3009508) Creatinine [Moles/volume] in Urine

162

3.30

5.32

5.1

3.0

6.60

8.08

mmol/l

0.95

140

(3007853) Bacteria identified in Skin by Aerobe culture

3.99

5.04

5.3

1.6

—

(3012516) Albumin [Mass/volume] in Urine

154

3.12

4.82

5.3

3.0

33.26

34.27

mg/l

0.02

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3.40

4.75

2.7

2.5

2.58

2.34

g/l

1.25

(3022948) Iron [Moles/volume] in Serum or Plasma

3.28

4.61

3.0

2.4

10.87

13.28

umol/l

1.36

(3026493) Urate [Moles/volume] in Serum or Plasma

146

2.78

3.86

3.3

3.1

334.67

333.44

umol/l

0.02

131

(3044640) Blood type and Crossmatch panel - Blood

179

2.71

3.78

3.0

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3.17

3.77

6.2

6.9

1.16

1.03

mmol/l

0.95

(3042936) Bacteria identified in Isolate by Culture

2.94

3.46

2.9

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

7.68

3.46

1.9

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

7.68

3.46

1.9

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

7.68

3.46

1.9

1.4

—

(3023368) Bacteria identified in Blood by Culture

139

2.61

3.36

4.8

4.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.97

3.32

1.7

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

166

2.50

3.18

2.4

1.5

21.53

20.68

nmol/l

0.10

144

(3032080) INR in Blood by Coagulation assay

253

2.51

3.18

9.1

12.3

1.21

1.19

inr

0.08

209

(3013826) Glucose [Moles/volume] in Serum or Plasma

315

2.57

3.01

5.2

4.7

7.40

6.46

mmol/l

1.49

291

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

7.20

2.93

1.5

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4.01

2.69

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

266

2.31

2.67

3.8

2.7

—

estimate

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

7.61

2.59

1.0

1.6

—

(3025941) Bacteria identified in Stool by Culture

3.50

2.57

1.8

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

261

2.24

2.51

9.3

7.2

1.20

1.22

mmol/l

0.72

225

(3007164) IgA [Mass/volume] in Serum or Plasma

137

2.19

2.24

1.3

2.73

2.28

g/l

0.81

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

4.60

2.20

1.2

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

444

2.55

2.02

4.6

4.7

14.39

14.61

pmol/l

0.26

416

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

129

2.07

1.88

3.0

2.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

4.41

1.86

2.4

1.6

10.90

5.28

pmol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.71

1.66

1.4

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

213

1.87

1.65

5.1

4.2

80.54

30.19

ng/l

0.53

134

(3022313) Gas panel - Capillary blood

2.89

1.63

11.9

3.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.89

1.63

2.0

1.3

—

(42870588) Differential panel, method unspecified - Blood

197

1.85

1.58

6.9

6.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.78

1.56

8.3

8.0

95.70

95.50

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

451

2.17

1.52

10.4

9.1

91.31

75.42

u/l

2.33

427

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.68

1.50

3.6

2.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2.58

1.43

8.0

7.4

0.41

0.67

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

3.10

1.38

1.2

1.6

3.18

3.21

g/l

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.65

1.33

1.0

1.8

0.25

0.24

g/l

—

(3013512) EKG study

189

1.73

1.29

5.4

3.7

—

(3000991) Gas panel - Venous blood

2.32

1.26

8.5

10.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.26

1.23

1.1

2.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

157

1.72

1.18

1.3

0.87

1.57

u/ml

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2.62

1.17

1.0

1.5

—

(40768443) Skin Pathology biopsy report

2.49

1.16

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.09

1.13

3.6

3.8

—

(3037522) Nuclear Ab [Titer] in Serum

1.88

1.12

1.5

144.00

514.67

titre

—

(4035726) Immunohistochemistry procedure

2.16

1.10

1.0

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

197

1.63

1.07

3.6

3.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

530

2.22

1.07

5.4

4.0

1.57

1.26

mmol/l

1.37

498

(40768797) Stomach Pathology biopsy report

1.82

1.05

1.1

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2.34

0.96

1.2

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2.17

0.92

9.5

7.6

0.80

1.11

—

(3023420) DNA double strand Ab [Units/volume] in Serum

2.03

0.87

1.0

2.3

—

5.08

—

(3002256) Pathology report gross observation

1.73

0.86

1.4

1.2

—

(3022145) Colonoscopy Study observation

1.80

0.85

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.80

0.0

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.17

0.76

1.2

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2.17

0.76

1.0

1.8

1.50

1.09

g/l

—

(3030467) Casts [#/volume] in Urine by Automated count

155

1.52

0.76

3.1

0.14

0.41

e6/l

0.89

119

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.62

0.74

1.7

1.8

—

(3003396) Base excess in Arterial blood by calculation

1.64

0.73

7.3

5.8

0.57

1.38

mmol/l

—

(3002582) Erythrocytes [#/volume] in Urine

184

1.48

0.72

2.9

3.3

12.52

354.24

e6/l

0.51

148

(1761868) Lipid panel - Serum or Plasma

259

0.67

0.71

4.2

2.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.66

0.63

9.1

6.1

103.30

104.69

mmol/l

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

246

1.41

0.62

2.0

1.8

1.74

1.35

mmol/l

0.80

211

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.59

0.57

1.0

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.68

0.57

8.3

4.8

24.83

26.02

mmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.52

0.56

1.6

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.56

0.55

3.0

2.8

10.40

3.06

e6/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

129

1.43

0.53

2.2

1.7

—

(3026008) Bacteria identified in Urine by Culture

167

1.38

0.50

2.8

2.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

1.5

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.42

0.0

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.41

0.0

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.51

0.41

1.2

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.51

0.41

1.8

1.6

444.36

1114.40

mu/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.51

0.41

1.2

2.1

—

(36304419) Bacteria [Presence] in Urine

154

1.33

0.40

3.3

3.0

—

estimate

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.41

0.37

1.5

—

(3018095) Leukocytes [#/volume] in Urine

213

1.28

0.37

3.8

3.9

13.07

40.79

e6/l

0.88

151

(3023323) Follitropin [Units/volume] in Serum or Plasma

1.33

0.34

1.0

1.3

12.50

25.28

iu/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.33

0.31

4.3

7.1

—

(40761536) Microorganisms panel - Urine sediment

1.28

0.30

3.9

3.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

243

0.80

0.30

3.7

3.9

0.00

estimate

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.25

0.27

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

547

1.34

0.23

6.6

4.7

6.62

5.82

mmol/l

2.36

517

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.21

0.0

1.8

—

9.82

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

30.65

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.21

0.0

2.5

—

90.69

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

0.12

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.00

0.21

0.0

2.3

—

8.02

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

2.5

—

0.54

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.20

0.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

0.00

0.20

0.0

1.2

—

12.48

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

110

1.23

0.19

1.5

2.0

—

(36660697) Celiac disease serology panel - Serum

1.21

0.19

1.3

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.14

0.18

2.9

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.16

0.17

1.3

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.14

0.16

1.8

—

(3003694) ABO and Rh group [Type] in Blood

162

1.15

0.13

1.7

1.5

—

(3000494) Fungus identified in Specimen by Culture

1.07

0.08

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.79

0.08

1.2

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

192

0.91

0.06

3.3

3.5

0.00

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

318

1.08

0.06

4.0

4.1

0.00

estimate

—

(3015736) pH of Urine

250

1.07

0.04

3.8

3.4

5.97

6.14

0.40

139

(3021601) Nitrite [Presence] in Urine by Test strip

312

1.05

0.02

4.1

4.0

0.00

estimate

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

104

1.07

0.01

1.5

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

176

0.95

0.00

4.1

4.0

0.00

estimate

—

(40758558) Short blood count panel - Blood

181

0.99

0.00

5.9

6.8

—

(40768804) Tissue Pathology biopsy report

239

1.01

0.00

2.5

2.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

153

0.97

0.00

4.7

5.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

379

1.01

0.00

4.1

3.2

—

(3035350) Ketones [Presence] in Urine by Test strip

315

1.03

0.00

3.8

4.0

0.00

estimate

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

249.67

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

2.0

—

(4195642) Thrombophilia screening test

0.00

0.0

1.0

—

(44806420) Estimation of glomerular filtration rate

0.00

0.0

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.0

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.0

1.3

—

0.64

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.2

—

6.68

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.0

—

47.00

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

150.75

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

4.4

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.3

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

3.0

—

9.22

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

7.0

—

140.75

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

3.6

—

10.46

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

313.40

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

2.2

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

1.2

—

16.16

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

2.30

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

-0.00

0.0

2.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

0.62

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

3.6

—

4.60

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

13.70

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

73.60

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.9

—

3.83

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

593

1.15

-0.00

17.4

12.4

30.47

25.50

u/l

1.45

582

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

0.00

-0.00

0.0

1.2

—

14.67

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.9

—

105.57

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

-0.00

0.0

2.8

—

15.98

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

0.92

-0.00

1.3

1.7

—

(21494815) CD4 cells/Lymphocytes in Specimen

0.00

-0.00

0.0

1.4

—

37.56

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

-0.00

0.0

1.9

—

231.33

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.9

—

1.21

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

1.1

—

91.60

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

9.06

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

393.60

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

3.4

—

33.00

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

1.63

—

(40768800) Prostate Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

4.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPERALISEQ and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_HYPERALISEQ.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: E4_HYPERALISEQ – Sequelae of hyperalimentation

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sequelae of hyperalimentation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints